Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.


SecurityADVM / Adverum Biotechnologies, Inc. (00773U108)
SVP, CFO, Interim Pres and CEOPATTERSON LEONE D
IndustryBiological Products, Except Diagnostic Substances (Biotech)
Institutional Owners103
Institutional Shares39,259,242 - 63.04%
Common Shares Outstanding62,271,901 shares (as of 2018-03-31)
Institutional Value$ 218,118,000 USD

Institutional Stock Ownership and Shareholders()

ADVM / Adverum Biotechnologies, Inc. Institutional Ownership

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) has 103 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 39,259,242 shares. Largest shareholders include Renaissance Technologies LLC, Adage Capital Partners GP LLC, Highbridge Capital Management Llc, JP Morgan Chase & Co, Driehaus Capital Management Llc, Vanguard Group Inc, Millennium Management Llc, Alkeon Capital Management Llc, Citadel Advisors Llc, and Citadel Advisors Llc.
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/advm"><img src="https://images.fintel.io/us-advm-so.png" alt="ADVM / Adverum Biotechnologies, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-04-26 13F-HR SIMPLEX TRADING, LLC 28,911 39,932 38.12 101 231 128.71
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Call 0 131,400 0 762
2018-05-15 13F-HR MANGROVE PARTNERS 424,538 0 -100.00 1,486 0 -100.00
2018-05-03 13F-HR MEEDER ASSET MANAGEMENT INC 1,546 0 -100.00 5 0 -100.00
2018-05-15 13F-HR HIGHBRIDGE CAPITAL MANAGEMENT LLC Call 400,000 400,000 0.00 1,400 2,320 65.71
2018-05-14 13F-HR PRIMECAP MANAGEMENT CO/CA/ 503,400 503,400 0.00 1,762 2,920 65.72
2018-05-15 13F-HR DEERFIELD MANAGEMENT CO 0 422,000 0 2,448
2018-05-15 13F-HR Iguana Healthcare Management, LLC 200,000 200,000 0.00 700 1,160 65.71
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 337,956 17,223 -94.90 1,183 100 -91.55
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 216,010 36,200 -83.24 756 210 -72.22
2018-05-15 13F-HR PANAGORA ASSET MANAGEMENT INC 90,195 7,655 -91.51 316 44 -86.08
2018-05-14 13F-HR FMR LLC / Fidelity 550,086 993,283 80.57 1,925 5,761 199.27
2017-02-13 13F-HR VHCP Management, LLC 1,102,735 1,102,735 0.00 4,532 3,198 -29.44
2018-05-14 13F-HR Rubric Capital Management LP 800,000 0 -100.00 2,800 0 -100.00
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 67,500 127,700 89.19 236 741 213.98
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 47,189 1,374,678 2,813.13 165 7,973 4,732.12
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 0 7,608 0 44
2018-05-10 13F-HR FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. 20,000 20,000 0.00 70 116 65.71
2018-05-15 13F-HR Weiss Asset Management LP 14,596 85
2018-04-26 13F-HR SIMPLEX TRADING, LLC Put 1 18 1,700.00 0 3
2018-05-03 13F-HR Jacobi Capital Management LLC 200 200 0.00 1 1 0.00
2018-05-14 13F-HR BOOTHBAY FUND MANAGEMENT, LLC 48,610 133,031 173.67 170 772 354.12
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 22,100 35,100 58.82 77 204 164.94
2018-05-15 13F-HR OXFORD ASSET MANAGEMENT 38,988 270,811 594.60 138 1,571 1,038.41
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 0 19,053 0 111
2018-05-15 13F-HR NEXTHERA CAPITAL LP 501,183 2,907
2018-04-10 13F-HR Hartford Financial Management Inc. 2,000 4,500 125.00 7 26 271.43
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 97,329 634,545 551.96 341 3,680 979.18
2018-05-08 13F-HR Alambic Investment Management, L.P. 50,413 292
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 6 6 0.00 21 35 66.67
2018-05-15 13F-HR PERCEPTIVE ADVISORS LLC 0 80,845 0 469
2018-05-02 13F-HR ALGERT GLOBAL LLC 72,980 423
2018-05-15 13F-HR Atika Capital Management LLC 195,000 1,131
2018-05-11 13F-HR JW Asset Management, LLC 178,654 0 -100.00 625 0 -100.00
2018-05-15 13F-HR DRIEHAUS CAPITAL MANAGEMENT LLC 0 1,870,939 0 10,851
2018-05-09 13F-HR IFP Advisors, Inc 6,000 6,000 0.00 21 35 66.67
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 2,500 1,241 -50.36 9 7 -22.22
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 138,940 534,312 284.56 486 3,099 537.65
2018-05-15 13F-HR ARDSLEY ADVISORY PARTNERS 100,000 100,000 0.00 350 580 65.71
2018-05-14 13F-HR DRW Securities, LLC 30,000 25,000 -16.67 105 145 38.10
2018-05-15 13F-HR VANGUARD GROUP INC 857,108 1,817,377 112.04 3,000 10,540 251.33
2018-07-17 13F-HR FOX RUN MANAGEMENT, L.L.C. 10,916 15,100 38.33 63 80 26.98
2018-05-15 13F-HR DEUTSCHE BANK AG\ 383,330 254,638 -33.57 1,341 1,476 10.07
2018-05-15 13F-HR BlueCrest Capital Management Ltd 31,691 159,162 402.23 111 923 731.53
2018-05-16 13F-HR Alpine Partners VI, LLC 20,713 0 -100.00 72 0 -100.00
2017-02-10 13F-HR BlackRock Advisors LLC 11,531 12,128 5.18 47 35 -25.53
2018-05-08 13F-HR ClariVest Asset Management LLC 58,200 337
2018-05-15 13F-HR Castle Hook Partners LP 577,778 3,351
2018-05-15 13F-HR Cubist Systematic Strategies, LLC 45,245 262
2018-05-15 13F-HR STATE STREET CORP 13,908 46,532 234.57 50 270 440.00
2018-05-15 13F-HR HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,300,000 2,100,000 -8.70 8,050 12,180 51.30
2018-04-30 13F-HR Monarch Partners Asset Management LLC 36,915 214
2018-05-15 13F-HR JACOBS LEVY EQUITY MANAGEMENT, INC 88,591 69,891 -21.11 310 405 30.65
2018-05-14 13F-HR Virtu Financial LLC 0 20,123 0 117
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Put 25,100 36,100 43.82 88 209 137.50
2018-05-15 13F-HR ELEMENT CAPITAL MANAGEMENT LLC 0 103,900 0 603
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 0 387 0 2
2018-06-28 13F-HR/A BROWN ADVISORY INC 15,985 93
2018-05-15 13F-HR Adage Capital Partners GP LLC 2,500,000 3,500,000 40.00 8,750 20,300 132.00
2018-05-15 13F-HR Sessa Capital IM, L.P. 638,712 0 -100.00 2,235 0 -100.00
2018-05-10 13F-HR Spark Investment Management LLC 66,821 0 -100.00 233 0 -100.00
2017-02-10 13F-HR BlackRock Investment Management, LLC 109,597 109,597 0.00 450 318 -29.33
2018-07-17 13F-HR Edge Wealth Management LLC 250 0 -100.00 1 0 -100.00
2018-05-15 13F-HR Polar Capital LLP 400,000 2,320
2018-05-04 13F-HR SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000 480,000 0.00 1,680 2,784 65.71
2018-05-15 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 183,900 189,200 2.88 644 1,097 70.34
2018-05-15 13F-HR Bank of New York Mellon Corp 40,885 51,890 26.92 143 301 110.49
2018-05-15 13F-HR/A Sabby Management, LLC 300,000 198,964 -33.68 1,050 1,154 9.90
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 939,611 1,179,192 25.50 3,289 6,839 107.94
2018-05-15 13F-HR Squarepoint Ops LLC 0 29,642 0 172
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 457,325 478,837 4.70 1,880 1,389 -26.12
2018-05-15 13F-HR 683 Capital Management, LLC 550,000 0 -100.00 1,925 0 -100.00
2018-05-15 13F-HR BARCLAYS PLC 34,445 95,883 178.37 120 556 363.33
2018-05-15 13F-HR ALKEON CAPITAL MANAGEMENT LLC 1,495,097 8,672
2018-05-10 13F-HR Stratos Wealth Partners, LTD. 150 1
2018-04-18 13F-HR Creative Planning 0 12,933 0 75
2018-05-15 13F-HR Alyeska Investment Group, L.P. 90,999 528
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Put 18,000 104
2018-05-14 13F-HR Axa 0 39,800 0 231
2018-04-11 13F-HR Rhenman & Partners Asset Management AB 127,006 127,006 0.00 445 737 65.62
2018-05-11 13F-HR Tibra Equities Europe Ltd 108,061 627
2018-05-14 13F-HR RTW INVESTMENTS, LLC 0 175,208 0 1,016
2018-05-04 13F-HR VICTORY CAPITAL MANAGEMENT INC 163,580 949
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 241,422 1,668,299 591.03 845 9,676 1,045.09
2018-04-20 13F-HR JENNISON ASSOCIATES LLC 302,083 0 -100.00 1,057 0 -100.00
2018-05-15 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 0 4,000 0 23
2018-05-09 13F-HR FEDERATED INVESTORS INC /PA/ 2,407 1,150 -52.22 8 7 -12.50
2018-05-03 13F-HR Trexquant Investment LP 0 31,644 0 184
2018-02-14 13F-HR NUMERIC INVESTORS LLC 269,400 249,700 -7.31 983 874 -11.09
2018-05-11 13F-HR Russell Investments Group, Ltd. 53,657 22,700 -57.69 193 132 -31.61
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. 13,776 18,008 30.72 48 104 116.67
2018-05-15 13F-HR Rock Springs Capital Management LP 0 900,000 0 5,220
2018-05-14 13F-HR Tekla Capital Management LLC 743,974 0 -100.00 2,604 0 -100.00
2018-05-11 13F-HR CITADEL ADVISORS LLC Put 18,000 104
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 49,000 0 -100.00 172 0 -100.00
2018-05-15 13F-HR PDT Partners, LLC 0 385,700 0 2,237
2018-05-15 13F-HR D. E. Shaw & Co., Inc. 0 32,722 0 190
2018-05-01 13F-HR MIZUHO SECURITIES USA INC. 10,000 58
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 0 6,000 0 35
2018-05-15 13F-HR Verition Fund Management LLC 14,662 85
2018-06-14 13F-HR/A Dynamic Technology Lab Private Ltd 10,333 0 -100.00 36 0 -100.00
2018-05-11 13F-HR MACQUARIE GROUP LTD 2,397 0 -100.00 8 0 -100.00
2018-05-09 13F-HR NORTHERN TRUST CORP 80,350 99,838 24.25 281 579 106.05
2018-05-15 13F-HR/A Sabby Management, LLC Call 0 944 0 548
2018-05-14 13F-HR Renaissance Technologies LLC 2,554,677 3,731,577 46.07 8,941 21,643 142.06
2018-05-14 13F-HR BOGLE INVESTMENT MANAGEMENT L P /DE/ 0 31,732 0 184
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 95,252 281,354 195.38 333 1,631 389.79
2018-05-09 13F-HR BlackRock Inc. 398,817 692,792 73.71 1,396 4,019 187.89
2018-05-15 13F-HR Redmile Group, LLC 22,236 22,236 0.00 78 129 65.38
2018-05-11 13F-HR CITADEL ADVISORS LLC 1,374,678 7,973
2018-04-20 13F-HR Cable Hill Partners, LLC 3,000 3,000 0.00 13 16 23.08
2018-05-15 13F-HR Invesco Ltd. 0 73,046 0 424
2018-05-14 13F-HR MORGAN STANLEY 579,181 388,124 -32.99 2,028 2,251 11.00
2018-05-15 13F-HR Advisor Group, Inc. 2,000 2,000 0.00 7 12 71.43
2018-05-15 13F-HR Casdin Capital, LLC 0 300,000 0 1,740
2017-05-15 13F-HR R&F Capital Advisors LP 16,558 45
2017-08-14 13F-HR NUMERIC INVESTORS LLC 1,087,967 559,150 -48.61 2,938 1,398 -52.42
2017-02-10 13F-HR BlackRock Fund Advisors 1,194,090 758,714 -36.46 4,908 2,200 -55.18
2018-05-15 13F-HR JANE STREET GROUP, LLC 0 10,108 0 59
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. Call 0 20,000 0 116
2018-04-12 13F-HR ACADIAN ASSET MANAGEMENT LLC 50,603 293
2018-05-15 13F-HR Man Group plc 1,306,048 7,575
2018-05-10 13F-HR Artal Group S.A. 0 400,000 0 2,320
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 12,400 73,000 488.71 43 423 883.72
2018-05-15 13F-HR UBS Group AG 0 2,573 0 15
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 5,654 0 -100.00 20 0 -100.00
2018-05-15 13F-HR Jefferies Group LLC 0 14,900 0 86
2018-05-14 13F-HR Connor, Clark & Lunn Investment Management Ltd. 195,550 171,750 -12.17 684 996 45.61
2018-05-10 13F-HR JP Morgan Chase & Co 132,609 1,997,407 1,406.24 464 11,585 2,396.77

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Rounds Report: Nephros Posts Strong Preliminary Financial Results For Q2

2018-07-13 seekingalpha
The overall bioscience market traded with a mixed sentiment for the day. Nevertheless, many equities under over coverage continued to rally. (29-2)

Adverum: Assessing The Strong Prospects Of A Gene Therapy Innovator

2018-05-23 seekingalpha
Gene-based therapy is one of the major waves of medical innovation to power this century. FDA approval of Luxturna signaled a highly favorable regulatory environment for Adverum. (43-4)

Top Analyst Upgrades and Downgrades: Aimmune, Anadarko, Carrizo, Mastercard, PayPal, Spotify, Visa and More

2018-05-18 247wallst
Stocks were indicated marginally higher on Friday, but the direction of the day seems far from set in stone. The trend of endlessly buying the dips has not worked as well as it has in prior years. Now is a time when all investors should be considering how they want their investments positioned for the longer term. (72-2)

5 Biotech Stocks Set to Beat Estimates This Earnings Season

2018-05-08 zacks
The first-quarter earnings season is nearing its end with 80% of the S&P 500 companies having already reported their results. The results so far reflect all-around strength, with an above average proportion of companies beating both top- and bottom-line expectations. However, the stock market does not reflect this strength. Moreover, there is uncertainty in the market due to rising inflation and geopolitical tensions. (109-1)

Biotech Companies Continue to Shake Up Leadership with New Appointments

2018-05-08 biospace
There have been a number of leadership changes in biotech companies over the last week. BioSpace has put together a list of new c-suite level hires and position changes. (449-3)

CUSIP: 00773U108